Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
455.22B
Market cap455.22B
Price-Earnings ratio
19.89
Price-Earnings ratio19.89
Dividend yield
2.73%
Dividend yield2.73%
Average volume
10.57M
Average volume10.57M
High today
$189.78
High today$189.78
Low today
$186.94
Low today$186.94
Open price
$187.00
Open price$187.00
Volume
5.09M
Volume5.09M
52 Week high
$189.78
52 Week high$189.78
52 Week low
$140.68
52 Week low$140.68

JNJ News

TipRanks 52m
Analyst Sees ‘Attractive Entry Point’ for Johnson & Johnson Stock after Trump-Pfizer Deal

The shares of pharmaceutical giant Johnson & Johnson (JNJ) rose on Friday afternoon after the stock earned new price boosts from U.S. banking titans Wells Fargo...

Nasdaq 6h
Validea Detailed Fundamental Analysis - JNJ

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor mod...

Validea Detailed Fundamental Analysis - JNJ
TipRanks 8h
Johnson & Johnson price target raised to $198 from $175 at BofA

BofA raised the firm’s price target on Johnson & Johnson (JNJ) to $198 from $175 and keeps a Neutral rating on the shares. While the timing of President Trump’s...

Analyst ratings

52%

of 25 ratings
Buy
52%
Hold
44%
Sell
4%

More JNJ News

TipRanks 9h
Wells upgrades Johnson & Johnson to Overweight on reduced concerns

Wells Fargo analyst Larry Biegelsen upgraded Johnson & Johnson to Overweight from Equal Weight with a price target of $212, up from $170. The firm says its conc...

Nasdaq 1d
JNJ November 14th Options Begin Trading

Investors in Johnson & Johnson (Symbol: JNJ) saw new options become available today, for the November 14th expiration. At Stock Options Channel , our YieldBoost...

JNJ November 14th Options Begin Trading
TipRanks 1d
Dentsply Sirona appoints Denti as Chief Commercial Officer

Dentsply Sirona (XRAY) announced that Aldo Denti has been appointed Executive Vice President and Chief Commercial Officer, CCO, effective October 6, 2025. Denti...

TipRanks 2d
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts

Nanobiotix (NBTX) announced first data from cohorts 1 and 2 of the dose escalation part of a Phase 1 dose escalation and dose expansion study evaluating JNJ-190...

The Motley Fool 2d
Should You Buy Kenvue Stock After Its 30% Plunge?

There hasn't been much good news lately for this Johnson & Johnson spinoff. Johnson & Johnson (JNJ 2.09%) spun off its consumer health unit as a separate entit...

Should You Buy Kenvue Stock After Its 30% Plunge?
Nasdaq 3d
EnGene Appoints Hussein Sweiti As Chief Medical Officer

(RTTNews) - Genetic medicine company enGene Holdings Inc. (ENGN) announced Tuesday that Hussein Sweiti was appointed Chief Medical Officer, effective September...

EnGene Appoints Hussein Sweiti As Chief Medical Officer
Nasdaq 3d
JNJ Crosses Above Average Analyst Target

In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $180.54, changing hands for $181.62...

JNJ Crosses Above Average Analyst Target

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.